Literature DB >> 4040396

Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.

M Einarsson, J Brandt, L Kaplan.   

Abstract

Tissue plasminogen activator produced by a human melanoma cell line (Bowes), was purified from large volumes of supernatant fluid using immunosorbent chromatography on monoclonal antibodies, followed by chromatography on lysine-Sepharose 4B and gel filtration on Sephadex G-150. Immunosorbents based on monoclonal antibodies were shown to be preferable to those based on polyclonal antibodies for several reasons: efficient binding and desorption, high yield along with a high degree of purification. The overall recovery was about 50%. A homogeneous sample of single-chain tissue plasminogen activator with a molecular weight of approx. 65 000 was obtained as judged by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate. Amino acid sequence analysis revealed two N-terminals in equal yields, corresponding to the long and short tissue plasminogen activator structures previously reported by others. The pure preparations of tissue plasminogen activator showed specific activities of about 200 000 IU/mg protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040396     DOI: 10.1016/0167-4838(85)90123-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

Review 2.  Immunoaffinity chromatography.

Authors:  G W Jack
Journal:  Mol Biotechnol       Date:  1994-02       Impact factor: 2.695

3.  Separation and characterization of the two Asn-linked glycosylation sites of chicken serum riboflavin-binding protein. Glycosylation differences despite similarity of primary structure.

Authors:  J S Rohrer; H B White
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

4.  The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans.

Authors:  A J Jaques; G Opdenakker; T W Rademacher; R A Dwek; S E Zamze
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 5.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

Review 6.  Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.

Authors:  Arnaud Chevilley; Flavie Lesept; Sophie Lenoir; Carine Ali; Jérôme Parcq; Denis Vivien
Journal:  Front Cell Neurosci       Date:  2015-10-16       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.